What’s your story, morning glory? Scientists use CRISPR technology to change flower colour in an ornamental plant
In a world-first, Japanese scientists have used the revolutionary CRISPR, or CRISPR/Cas9, genome- editing tool to change flower colour in an ornamental plant. Researchers from the University of Tsukuba, the National Agriculture and Food Research Organization (NARO) and Yokohama City University, Japan, altered the flower colour of the traditional Japanese garden plant, Japanese morning glory (Ipomoea nil or Pharbitis nil), from violet to white, by disrupting a single gene. This research highlights the huge potential of the CRISPR/Cas9 system to the study and manipulation of genes in horticultural plants.
Japanese morning glory, or Asagao, was chosen for this study as it is one of two traditional horticultural model plants in the National BioResource Project in Japan (NBRP). Extensive genetic studies of this plant have already been performed, its genome sequenced and DNA transfer methods established. In addition, as public concern with genetic technologies such as CRISPR/Cas9 is currently a social issue in Japan, studies using this popular and widely-grown plant may help to educate the public on this topic.
The research team targeted a single gene, dihydroflavonol-4-reductase-B (DFR-B), encoding an anthocyanin biosynthesis enzyme, that is responsible for the colour of the plant’s stems, leaves and flowers. Two other, very closely related genes (DFR-A and DRF-C) sit side-by-side, next to DFR-B. Therefore, the challenge was to specifically and accurately enzyme DFR-B gene without altering the other genes. The CRISPR/Cas9 system was used as it is currently the most precise method of gene editing.
The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 system is based on a bacterial defense mechanism. It is composed of two molecules that alter the DNA sequence. Cas9, an enzyme, cuts the two strands of DNA in a precise location so that DNA can be added or removed. Cas9 is guided to the correct location by gRNA, or guide RNA, a small piece of RNA that has been designed to be complementary to the target DNA sequence. Cas9 cuts the two strands of DNA at the target location, allowing DNA to be removed and/or added.
As reported on 30 August 2017 in Scientific Reports, a short DNA sequence in the Japanese morning glory DFR-B gene was selected as the target for the CRISPR/Cas9 system. This sequence contains the active site of the enzyme produced by the DFR-B gene. Disruption of this sequence should therefore de-activate the enzyme, resulting in an absence of the colour pigment, anthocyanin. The CRISPR/Cas9 system was inserted into tissue-cultured embryos of Japanese morning glory plants using the DNA-transferring capabilities of the plant bacterium Rhizobium. As expected, the DFR-B enzyme was successfully inactivated, resulting in approximately 75%of the transgenic plants with green stems and white flowers. Non-transformed plants with an active enzyme had violet stems and flowers. These changes in stem colour were observed very early in the tissue culture process. A series of genetic analyses confirmed that the DNA target sequence had been altered in the transgenic plants, with either DNA insertions or deletions in both copies of the DFR-B gene (so-called bi-allellic mutants). The other related genes, DFR-A and DFR-C, were examined and no mutations were found, confirming the high specificity of the CRISPR/Cas9 system.
Next, the researchers examined the inheritance of the CRISPR/Cas9-induced mutations by analyzing plants from the next generation. These plants looked exactly like their parents. Among these plants were some without any sign of the introduced DNA. This raises some interesting questions in terms of the regulation of genetically modified organisms (GMOs), as these next-generation plants are considered transgenic, based on process-based definitions (how they were made), and non- transgenic, based on product-based definitions (the presence of foreign DNA in the final product).
This technology is also extremely useful in confirming the function of genes. Experiments in the 1930s and 1990s used ‘forward’ genetic screening techniques to find the genes responsible for flower colour production in the Japanese morning glory. The CRISPR/Cas9 system described here is the ‘reverse’ genetic approach, used to find out what an organism looks like after a known gene is disrupted, and confirms that the DFR-B gene is the main gene responsible for colour in Japanese morning glory plants.
Currently, CRISPR/Cas9 technology is not 100% efficient, that is, not all targeted plants will be transgenic. The mutation rate in this study, 75%, however, was relatively high. This is one of the reasons this research will greatly facilitate those interested in the modification of flower colours and shapes using the CRISPR/Cas9 system in ornamental flowers or vegetables.
The story of the Japanese morning glory started in the 8th century AD, with the introduction of wild blue-flowered plants into Japan from China. In 1631, the first white-flowered Japanese morning glory was painted in Japan. What took nature nearly 850 years to achieve has taken less than one using the CRISPR/Cas9 system, indicating both its power and its potential.
The Latest on: CRISPR/Cas9
A Yield Revolution in Row Crops Cometh
on May 23, 2018 at 11:40 am
Yield10’s Brave New World of Metabolic Engineering, Benson Hill’s cloud biology and CRISPR/Cas9 from Purdue and the Chinese Academy of Sciences? Crop yield may never be the same. And developers using crops for bioindustrials or nutrition stand to reap ... […]
Scientists Use CRISPR to Block HIV Replication Inside Living Cells
on May 23, 2018 at 10:02 am
Researchers from Japan’s Kobe University say they’ve successfully used the CRISPR/Cas9 gene editing platform to block the replication of HIV in living cells. Around 35 million people around the world are infected with HIV, but many of them keep their ... […]
Genome Editor CRISPR Targets AIDS Virus HIV
on May 22, 2018 at 2:07 pm
Thanks to genome-editing system CRISPR/Cas9, Japanese researchers are one step closer to curing HIV. Human immunodeficiency virus-1 (HIV-1) is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by ... […]
CRISPR-edited rice plants produce major boost in grain yield
on May 22, 2018 at 3:04 am
Jian-Kang Zhu’s research team used CRISPR/Cas9 gene-editing technology to silence a suite of genes in rice, leading to a variety that yields as much as 31 percent more grain. Credit: Purdue University A team of scientists from Purdue University and the ... […]
CRISPR-Cas9-based strategy allows researchers to precisely alter hundreds of different genes
on May 21, 2018 at 11:19 pm
Geneticists have been using model organisms ranging from the house mouse to the single-cell bakers' yeast, Saccharomyces cerevisiae, to study basic biological processes that regulate human development and physiology, and that can be compromised in various ... […]
Profiling the genome hundreds of variations at a time
on May 21, 2018 at 7:26 pm
Using baker's yeast, a team at Harvard's Wyss Institute developed a CRISPR-Cas9-based high-throughput approach that allows researchers to precisely alter hundreds of different genes or features of a single gene at once in individual yeast cells with 80 to ... […]
Gene editing: Better crops, fewer regulations?
on May 21, 2018 at 7:35 am
The CRISPR-Cas9 gene editing method — which allows undesirable genes in a plant to be easily “snipped” out in order to enhance flavor, retard spoilage, make it grow tall instead of drooping, become unattractive to insects or diseases, resist drought ... […]
CRISPR Eradicates Latent HIV-1, Offering Hope of "Functional Cures"
on May 21, 2018 at 7:03 am
Scientists in Japan have used CRISPR-Cas9 technology to stop human immunodeficiency virus type 1 (HIV-1) replication in latently infected T cells that can’t be controlled using existing drug treatments. The gene-editing approach effectively disrupts two ... […]
New CRISPR/Cas9 system targets regulatory genes of AIDS virus
on May 18, 2018 at 5:52 pm
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. It is hard to eradicate cells ... […]
ToolGen, Inc., Demonstrates CRISPR/cas9 Gene Editing Improves Anti-Tumor Activity of Human CAR-T Cells
on May 17, 2018 at 1:43 pm
Data Presented at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting SEOUL, South Korea, May 17, 2018 (GLOBE NEWSWIRE) -- ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, today announced data ... […]
via Google News and Bing News